Wednesday, 21 August 2019

Pharma News

  • FDA accepts sNDA for Astellas cancer drug

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 17 Jan, 2013

    Singapore: The US FDA has accepted Astellas Pharma's US subsidiary filing of a supplemental New Drug Application (sNDA) for Tarceva (erlotinib) for first-line use in people with locally adv...Read more

  • AstraZeneca, BMS gets FDA nod for diabetes drug

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 09 Jan, 2014

    Singapore: AstraZeneca and Bristol-Myers Squibb have recieved U.S. Food and Drug Administration (FDA) approval for diabetes drug Farxiga (dapagliflozin). AstraZeneca and Bristol-Myers Squi...Read more

  • EMA to review marketing plea for antipsychotic medication

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 29 Oct, 2012

    Singapore: The European Medicines Agency (EMA) has accepted the marketing authorization application for review of an atypical antipsychotic medication lurasidone hydrochloride. The product ...Read more

  • Leo launches psoriasis education program

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jan, 2013

    Singapore: Leo Pharma launched Psoriasis Coach All-Round Education (PsorCARE) program in Singapore on January 26, 2013. Developed by LEO Pharma Asia and PsorAsia, PsorCARE's goal is to enh...Read more

  • Chipscreen gets SFDA nod after accelerated review

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 17 Apr, 2013

    ‎Singapore: China-based Chipscreen Biosciences announced the achievement of the primary endpoint in the pivotal, registrational phase II Chipel trial of Chidamide (Epidaza), an orally...Read more

  • Bird flu cases erupt in Cambodia

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 04 Feb, 2013

    Singapore: Cambodia's Ministry of Health (MoH) has reported five new human cases of avian influenza (bird flu), which were confirmed positive for the H5N1 virus in January 2013. The five ...Read more

  • Indian pharma clocks 8.9% growth in June 2013: IMS

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jul, 2013

    New Delhi: The IMS Health Total Sales Audit (TSA) has released a report stating that the Indian pharmaceutical market has clocked a growth of 8.9 percent during the month of June 2013. The...Read more

  • Sanofi withdraws diabetes drug NDA in the US

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 13 Sep, 2013

    Singapore: Global pharmaceutical company, Sanofi has temporarily withdrawn new drug application (NDA) for lixisenatide in the US and plans to resubmit in 2015.Lixisenatide is approved in Eu...Read more

  • Antithrombotic drug market to be $24 bn by 2015

    Pharma |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Feb, 2013

    Singapore: Visiongain, a business information provider, estimates in its report 'Antithrombotic Drugs: World Market 2013-2023' that the global antithrombotic drug market to reach revenue of...Read more

  • Ranbaxy advisory: All our products are safe and efficacious

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 03 Jun, 2013

    New Delhi: Ranbaxy issued an advisory claiming that all their products in the Indian and global markets are safe and efficacious. The firm revealed that the advisory was issued in public i...Read more

  • Amgen to acquire Onyx for $10 bn cash

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 26 Aug, 2013

    Singapore: Global biopharmaceutical company Amgen plans to acquire all the outstanding shares of Onyx Pharmaceuticals for $125-per-share, totalling to $10.40 billion, in cash. The deal woul...Read more

  • Rabies claims 100 lives annually in Vietnam: UN

    Pharma |  Analysis | By BioSpectrum Bureau  | 0 Comment | 30 Sep, 2013

    Singapore: Vietnam has seen a substantial increase in the number of rabies fatalities from 34 deaths in 2003 to 131 deaths in 2007, according to United Nations (UN). World Rabies Day, whic...Read more

  • GSK Parkinson's drug can make you homosexual

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 03 Dec, 2012

    Singapore: A landmark appeal court ruling in Britain has ordered British drug giant GlaxoSmithKline (GSK) to provide compensation worth $256,384 (£160,000) to 52-year-old Mr Didier Jambart...Read more

  • QIAGEN reports 9% growth in Q2 2012

    Pharma |  Company results | By BioSpectrum Bureau  | 0 Comment | 25 Jul, 2012

    Singapore: QIAGEN reported results of operations for the second quarter and first half of 2012, delivering a solid performance and making significant progress on strategic initiatives to dr...Read more

  • AstraZeneca makes initial payment of $3.2 billion to Amylin

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 10 Aug, 2012

    Singapore: Following the successful completion of the acquisition of Amylin Pharmaceuticals by Bristol-Myers Squibb, AstraZeneca has made an initial payment of approximately $3.2 billion to...Read more

  • Effient trial by Daiichi, Lilly fails to meet primary endpoint

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 27 Aug, 2012

    Singapore: The TRILOGY ACS study, a phase III trial comparing prasugrel plus aspirin to clopidogrel plus aspirin in patients with unstable angina (UA) or non-ST elevation myocardial infarct...Read more

  • Top 20: Singapore - High growth

    Pharma |  Analysis | By BioSpectrum Bureau  | 0 Comment | 09 Jul, 2014

    Singapore: Singapore has been witnessing strong performance. Here are a few developments in the country that are proof to increasing its bioscience presence. Alcon, global eye-care firm,...Read more

  • Now Ranbaxy's Mohali unit under FDA scanner

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jun, 2013

    Singapore: Merely a month after Indian drug major, Ranbaxy, pleaded guilty of having misled the USFDA investigations, selling adulterated drugs in the US and paying a penalty of $500 millio...Read more



Podcast

 

Survey Box

Will APAC lead the way for innovation in the field of precision medicine?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls